Moderna (Nasdaq: MRNA) has received a potential $1.74 billion contract to initially produce and deliver 66 million doses of its
Moderna has been awarded a potential $472M contract modification by the Biomedical Advanced Research and Development Authority to expand late-stage clinical trials of the…
The Biomedical Advanced Research and Development Authority has awarded Moderna a potential $483M contract to further develop a vaccine against to…
